Skip to content

Clinical trials

Neoplasms trials in China with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Status: Unknown status Country / region: China Clear all

198 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20071
20093
20113
20128
20133
20147
20156
201613
201719
201816
20199
202021
202126
202222
202329
202410

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status198

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University11
Chinese Academy of Medical Sciences5
Peking Union Medical College Hospital5
First Affiliated Hospital of Fujian Medical University4
Peking University Cancer Hospital & Institute4
Shanghai Zhongshan Hospital4
Shenzhen Hornetcorn Bio-technology Company, LTD4
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology4
Affiliated Hospital of Jiangnan University3
Cancer Institute and Hospital, Chinese Academy of Medical Sciences3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms198
Neoplasm Metastasis10
Breast Neoplasms7
Carcinoma7
Colorectal Neoplasms7
Ovarian Neoplasms7
Carcinoma, Non-Small-Cell Lung5
Lung Neoplasms5
Lymphoma5
Digestive System Neoplasms4

Trials

Showing 1 to 25 of 198. Each trial links to its page on Pharma Observatory.

98 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.